3126 Objectives: Myocardial Perfusion Imaging (MPI) plays an important role in the
noninvasive assessment of Coronary Artery Disease (CAD). For wider deployment of PET …

Objective 68 Ga-NOTA-RGD PET is a newly developed molecular imaging for angiogenesis.
In this study, 68 Ga-NOTA-RGD PET was used to investigate imaging characteristics in a rat …

PET allows for quantitative, regional myocardial perfusion imaging. The short half-lives of
the perfusion tracers currently in use limit their clinical applicability. Here, the biodistribution …

Myocardial perfusion imaging with PET offers several advantages over SPECT for the
detection and characterization of coronary artery disease. With PET, individual tissue …

The rat heart is an excellent model for the investigation of cardiac physiology and
metabolism. It has been used extensively for ex vivo studies of the normal heart as well as …

PURPOSE: We evaluated four potential gallium-68 (68Ga)-labeled tracers for positron
emission tomography (PET) imaging of myocardial perfusion in comparison with oxygen-15 …

22 Background: 18F-flurpiridaz is a promising PET agent for myocardial perfusion imaging
(MPI), but with the long half-life attention needs to be paid to the rest/stress imaging due to …

Abstract Background BMS-747158-02 is a fluorine 18-labeled pyridaben derivative
designed as a new myocardial perfusion imaging agent for use with positron emission …

Background Magnetic resonance imaging (MRI) with Gadolinium 1, 4, 7, 10-
tetraazacyclododecane-N′, N ″, N′′′, N ″″-tetraacetic acid (Gd-DOTA) enables …

418 Objectives Previous reports of BMS747158, demonstrated favorable bio-kinetics for PET
myocardial perfusion (MP) imaging. This study examined the impact of dose* acquisition …